Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 31

The DOI matches its Crossref record.

A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91–108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization

Ben-Yedidia, Tamar, Beignon, Anne-Sophie, Partidos, Charalambos D., Muller, Sylviane, Arnon, Ruth·2002·Molecular Immunology
DOI 10.1016/s0161-5890(02)00095-0
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0161-5890(02)00095-0

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 33

  1. Arnon, 1992, Structural basis of antigenic specificity and design of new vaccines, FASEB, 6, 3265, 10.1096/fasebj.6.14.1385242 · DOI
  2. Arulanandam, 2001, IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection, J. Immunol., 166, 226, 10.4049/jimmunol.166.1.226 · doi:10.4049/jimmunol.166.1.226
  3. Barrett, T., Inglis, S.C., 1985. Growth purification and titration influenza viruses. In: Mahy, W.J. (Ed.), Virology: A Practical Approach. IRL Press, Washington, DC, pp. 119–151.
  4. Baumgarth, 1996, In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the local cellular immune response in lung tissue, J. Virol., 70, 4411, 10.1128/JVI.70.7.4411-4418.1996 · DOI
  5. Ben-Yedidia, 1998, Efficacy of anti-influenza peptide vaccine in aged mice, Mech. Ageing Dev., 104, 11, 10.1016/S0047-6374(98)00045-1 · DOI
  6. Benkirane, 1995, Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle: specificity and kinetics rate constant measurements, J. Biol. Chem., 270, 11921, 10.1074/jbc.270.20.11921 · DOI
  7. Briand, 1995, Retro-inverso peptidomimetics as a new immunological probe: validation and application to the detection of autoantibodies in rheumatic diseases, J. Biol. Chem., 270, 20686, 10.1074/jbc.270.35.20686 · DOI
  8. Briand, 1997, A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies, Proc. Natl. Acad. Sci. U.S.A., 94, 12545, 10.1073/pnas.94.23.12545 · DOI
  9. Caton, 1982, The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype), Cell, 31, 417, 10.1016/0092-8674(82)90135-0 · DOI · Paper page
  10. Chorev, 1993, A dozen years of retro-inverso peptidomimetics, Acc Chem. Res., 26, 266, 10.1021/ar00029a007 · DOI · Paper page
  11. Disis, 1996, Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein, J. Immunol., 156, 3151, 10.4049/jimmunol.156.9.3151 · DOI · Paper page
  12. Gorse, 1995, Increased anti-influenza A virus cytotoxic T-cell activity following vaccination of the chronically ill elderly with live-attenuated or inactivated influenza virus vaccine, J. Infect. Dis., 172, 1, 10.1093/infdis/172.1.1 · DOI
  13. Guichard, 1994, Antigenic mimicry of natural l-peptides with retro-inverso peptidomimetics, Proc. Natl. Acad. Sci. U.S.A., 91, 9765, 10.1073/pnas.91.21.9765 · DOI · Paper page
  14. Hayashi, 2001, The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5, Nature, 410, 1099, 10.1038/35074106 · DOI · Paper page
  15. Levi, R., Arnon, R., 1995. Vaccines 95: effective protection of mice from viral challenge by an influenza synthetic recombinant vaccine with cross-strain specifity. CSHL Press, New York, pp. 311–316.
  16. Levi, 1996, Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection, Vaccine, 14, 85, 10.1016/0264-410X(95)00088-I · DOI
  17. McEwen, 1992, Synthetic recombinant vaccine expressing influenza hemagglutinin epitope in Salmonella flagellin leads to partial protection in mice, Vaccine, 10, 405, 10.1016/0264-410X(92)90071-Q · DOI
  18. Mitchell, 1985, The immunology of influenza, Br. Med. Bull., 41, 80, 10.1093/oxfordjournals.bmb.a072031 · DOI
  19. Muller, 1982, Anti-influenza response achieved by immunization with a synthetic conjugate, Proc. Natl. Acad. Sci. U.S.A., 79, 563, 10.1073/pnas.79.2.569 · doi:10.1073/pnas.79.2.569
  20. Nargi, 1999, Protection of swine from foot-and-mouth disease virus with one dose of an all-d retro-peptide, Vaccine, 17, 2888, 10.1016/S0264-410X(99)00127-9 · DOI · Paper page
  21. Newton, 1995, Expression and immunogenicity of an 18-residue epitope of HIV1 gp41 inserted in the flagellar protein of a Salmonella live vaccine, Res. Microbiol., 146, 203, 10.1016/0923-2508(96)80276-2 · doi:10.1016/0923-2508(96)80276-2
  22. Ostankovitch, 1998, A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope, J. Immunol., 161, 200, 10.4049/jimmunol.161.1.200 · DOI · Paper page
  23. Partidos, 2001, The bare skin and the nose as non invasive routes for administering peptide vaccines, Vaccine, 19, 2708, 10.1016/S0264-410X(00)00507-7 · DOI
  24. Peschke, 1993, Role of macrophage cytokines in influenza A virus infections, Immunobiology, 189, 340, 10.1016/S0171-2985(11)80365-7 · DOI
  25. Petit, 1999, Solution structure of a retro-inverso peptide analogue mimicking the foot-and-mouth disease virus major antigenic site: structural basis for its cross-reactivity with the parent peptide, J. Biol. Chem., 274, 3686, 10.1074/jbc.274.6.3686 · doi:10.1074/jbc.274.6.3686
  26. Phan Chan Du, 2001, Structure of antibody-bound peptides and retro-inverso analogues. A transferred nuclear Overhauser effect spectroscopy and molecular dynamics approach, Biochemistry, 40, 5720, 10.1021/bi001151h · doi:10.1021/bi001151h
  27. Shapira, 1984, Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of the hemagglutinin, Proc. Natl. Acad. Sci. U.S.A., 81, 2461, 10.1073/pnas.81.8.2461 · doi:10.1073/pnas.81.8.2461
  28. Shapira, 1985, A synthetic vaccine against influenza with build-in adjuvanticity, Int. J. Immunopharmacol., 7, 719, 10.1016/0192-0561(85)90157-2 · doi:10.1016/0192-0561(85)90157-2
  29. Stemmer, 1999, Protection against lymphocytic choriomeningitis virus infection induced by a reduced peptide bond analogue of the H-2b restricted CD8+ T-cell epitope GP33, J. Biol. Chem., 274, 5550, 10.1074/jbc.274.9.5550 · doi:10.1074/jbc.274.9.5550
  30. Stocker, 1994, Immune responses to epitopes inserted in Salmonella flagellin, Int. Rev. Immunol., 11, 167, 10.3109/08830189409061724 · doi:10.3109/08830189409061724
  31. Topham, 1996, Immune CD4+ T-cells promote the clearance of influenza virus from major histocompatibility complex class II −/− respiratory epithelium, J. Virol., 70, 1288, 10.1128/JVI.70.2.1288-1291.1996 · DOI
  32. Virelizier, 1979, Immune responses to influenza virus in the mouse and their role in control of the infection, Br. Med. Bull., 35, 65, 10.1093/oxfordjournals.bmb.a071544 · DOI
  33. Webster, 1982, Molecular mechanism of variation in influenza viruses, Nature, 296, 115, 10.1038/296115a0 · DOI · Paper page

Cited by

See all 31

Metadata

Authors
Ben-Yedidia, T., Beignon, A.-S., Partidos, C. D., Muller, S., & Arnon, R.
Venue
Molecular Immunology
Publisher
Elsevier BV
Published
2002-10
Volume
39
Issue
5-6
Pages
323-331
ISSN
0161-5890
DOI
10.1016/s0161-5890(02)00095-0
Cited by
31
References
0
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91–108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. https://app.cochat.ai/papers/10.1016/s0161-5890(02)00095-0
The paper
Ben-Yedidia, T., Beignon, A.-S., Partidos, C. D., Muller, S., & Arnon, R. (2002). A retro-inverso peptide analogue of influenza virus hemagglutinin B-cell epitope 91–108 induces a strong mucosal and systemic immune response and confers protection in mice after intranasal immunization. Molecular Immunology. https://doi.org/10.1016/s0161-5890(02)00095-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.